Home Applications 204819 Application 204819
Type NDA
Sponsor BAYER HLTHCARE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ADEMPAS RIOCIGUAT TABLET;ORAL 0.5MG Yes No 002 ADEMPAS RIOCIGUAT TABLET;ORAL 1MG Yes No 003 ADEMPAS RIOCIGUAT TABLET;ORAL 1.5MG Yes No 004 ADEMPAS RIOCIGUAT TABLET;ORAL 2MG Yes No 005 ADEMPAS RIOCIGUAT TABLET;ORAL 2.5MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N204819-001 ADEMPAS RIOCIGUAT 0.5MG TABLET / ORAL AB RLD 2013-10-08 N204819-002 ADEMPAS RIOCIGUAT 1MG TABLET / ORAL AB RLD 2013-10-08 N204819-003 ADEMPAS RIOCIGUAT 1.5MG TABLET / ORAL AB RLD 2013-10-08 N204819-004 ADEMPAS RIOCIGUAT 2MG TABLET / ORAL AB RLD 2013-10-08 N204819-005 ADEMPAS RIOCIGUAT 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 35 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N204819-001 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 N204819-001 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 N204819-001 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 N204819-001 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 N204819-001 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 N204819-001 12503469 2034-02-18 U-2834 Drug product 2026-01-21 N204819-001 12503469 2034-02-18 U-2835 Drug product 2026-01-21 N204819-002 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 N204819-002 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 N204819-002 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 N204819-002 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 N204819-002 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 N204819-002 12503469 2034-02-18 U-2834 Drug product 2026-01-21 N204819-002 12503469 2034-02-18 U-2835 Drug product 2026-01-21 N204819-003 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 N204819-003 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 N204819-003 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 N204819-003 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 N204819-003 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 N204819-003 12503469 2034-02-18 U-2834 Drug product 2026-01-21 N204819-003 12503469 2034-02-18 U-2835 Drug product 2026-01-21 N204819-004 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 N204819-004 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 N204819-004 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 N204819-004 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 N204819-004 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 N204819-004 12503469 2034-02-18 U-2834 Drug product 2026-01-21 N204819-004 12503469 2034-02-18 U-2835 Drug product 2026-01-21 N204819-005 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 N204819-005 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 N204819-005 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 N204819-005 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 N204819-005 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 N204819-005 12503469 2034-02-18 U-2834 Drug product 2026-01-21 N204819-005 12503469 2034-02-18 U-2835 Drug product 2026-01-21
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 205 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204819-001 ADEMPAS 0.5MG TABLET / ORAL AB RLD 2013-10-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204819-002 ADEMPAS 1MG TABLET / ORAL AB RLD 2013-10-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204819-003 ADEMPAS 1.5MG TABLET / ORAL AB RLD 2013-10-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204819-004 ADEMPAS 2MG TABLET / ORAL AB RLD 2013-10-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204819-005 ADEMPAS 2.5MG TABLET / ORAL AB RLD, RS 2013-10-08 5bbf6a4d5a75…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 135 observed states.
Observed Orange Book patent history# Patent history page 1 of 24 · 935 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N204819-001 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-001 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-001 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-001 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-001 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-001 12503469 2034-02-18 U-2834 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-001 12503469 2034-02-18 U-2835 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 12503469 2034-02-18 U-2834 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-002 12503469 2034-02-18 U-2835 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 12503469 2034-02-18 U-2834 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-003 12503469 2034-02-18 U-2835 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 12503469 2034-02-18 U-2834 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-004 12503469 2034-02-18 U-2835 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 12503469 2034-02-18 U-2834 Drug product 2026-01-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204819-005 12503469 2034-02-18 U-2835 Drug product 2026-01-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-001 7173037 2026-12-04 Drug substance, Drug product 2013-11-06 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-001 10662188 2034-02-18 U-2834 Drug substance, Drug product 2020-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-001 10662188 2034-02-18 U-2835 Drug substance, Drug product 2020-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-001 11203593 2034-02-18 U-2834 Drug substance, Drug product 2022-01-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204819-001 11203593 2034-02-18 U-2835 Drug substance, Drug product 2022-01-14 31067a03dcf5…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 30 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 50419-250 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-250 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-250 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-250 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-250 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-250 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-251 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-251 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-251 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-251 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-251 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-251 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-252 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-252 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-252 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-252 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-252 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-252 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-253 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-253 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-253 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-253 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-253 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-253 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-254 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-254 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-254 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-254 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-254 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current 50419-254 Adempas riociguat Bayer HealthCare Pharmaceuticals Inc. NDA Current